QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 297 filers reported holding QIAGEN NV in Q4 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $272,404 | -10.1% | 5,980 | -0.7% | 0.00% | -50.0% |
| Q4 2022 | $303,000 | -90.2% | 6,022 | -91.8% | 0.00% | -88.9% |
| Q3 2022 | $3,100,000 | -26.1% | 73,563 | -17.3% | 0.02% | -28.0% |
| Q2 2022 | $4,193,000 | -5.7% | 88,917 | -0.5% | 0.02% | +177.8% |
| Q1 2022 | $4,448,000 | -81.2% | 89,322 | -2.9% | 0.01% | -85.2% |
| Q4 2021 | $23,636,000 | +386.8% | 91,988 | -1.3% | 0.06% | +408.3% |
| Q3 2021 | $4,855,000 | -0.5% | 93,193 | -7.1% | 0.01% | 0.0% |
| Q2 2021 | $4,877,000 | -11.5% | 100,319 | -12.5% | 0.01% | -29.4% |
| Q1 2021 | $5,511,000 | -93.8% | 114,628 | -0.5% | 0.02% | -96.9% |
| Q4 2020 | $88,854,000 | +1404.0% | 115,213 | +0.6% | 0.55% | +837.3% |
| Q3 2020 | $5,908,000 | +15.5% | 114,535 | -4.4% | 0.06% | +9.3% |
| Q2 2020 | $5,114,000 | -6.3% | 119,803 | -10.4% | 0.05% | -18.2% |
| Q1 2020 | $5,459,000 | +11.8% | 133,703 | -7.8% | 0.07% | +53.5% |
| Q4 2019 | $4,882,000 | – | 145,087 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C M BIDWELL & ASSOCIATES LTD | 301,504 | $8,448,000 | 1.99% |
| PRIMECAP MANAGEMENT CO/CA/ | 19,143,036 | $536,388,000 | 0.53% |
| Granahan Investment Management | 535,700 | $15,010,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1,704,116 | $47,749,000 | 0.37% |
| BALYASNY ASSET MANAGEMENT L.P. | 914,759 | $25,608,000 | 0.14% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 626,250 | $17,548,000 | 0.02% |
| BALYASNY ASSET MANAGEMENT L.P. | 153,700 | $4,303,000 | 0.02% |
| Capital Research Global Investors | 2,259,565 | $63,393,000 | 0.02% |
| RHUMBLINE ADVISERS | 201,388 | $5,643,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 16,373 | $459,000 | 0.01% |